Qianqian Lei
Changsha, 410013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction: MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells.
Journal: Oncotarget
Published: December 21, 2020
LINC00470 Coordinates the Epigenetic Regulation of ELFN2 to Distract GBM Cell Autophagy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 25, 2018
NGL-2 Is a New Partner of PAR Complex in Axon Differentiation.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: May 08, 2015
MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells.
Journal: Oncotarget
Published: November 11, 2014
Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
Journal: Oncotarget
Published: August 31, 2014
LRRC4 haplotypes are associated with pituitary adenoma in a Chinese population.
Journal: Medical oncology (Northwood, London, England)
Published: December 10, 2013
miR-181 subunits enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeleton remodeling in glioblastoma cells.
Journal: Medical oncology (Northwood, London, England)
Published: November 25, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026